REGENXBIO Inc.
$644.27M- Market cap
- $590.16M
- Debt
- +$284.18M
- Cash
- −$230.07M
Capital structure 67% equity / 33% debt · EV / Revenue 3.78x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
RGNX · current priceP/S 3.46x
$8.94Latest market snapshot
Implied fair value · at AMN's multiple
$1.2486.2% below market
2.58 RGNX revenue / share×0.48x AMN P/S=$1.24
Market $8.94Implied $1.24
AMN · current priceP/S 0.48x
$33.80Latest market snapshot
Implied fair value · at RGNX's multiple
$244.11622.2% above market
70.50 AMN revenue / share×3.46x RGNX P/S=$244.11
Market $33.80Implied $244.11